Indrayani Biotech share news, announcements and annual reports
BSE: 526445Agricultural Food & other ProductsSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹7.81.
30 Oct: open ₹7.81, high ₹8.13, low ₹7.47
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹37 Cr3,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Owners' profit not stated
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.50
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.26
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 21,374
Indrayani Biotech share news and announcements
608 announcements, routine notices left out, newest first. Page 8 of 13.
Jan 2021
8 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 06 Jan · Announcement under Regulation 30 (LODR)-Meeting Updates
4 Jan · Intimation On The Outcome For The Board Meeting Held On 4Th January 2021 And Disclosure Under SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
2 Jan · Cash Flow Statement For The Quarter Ended 30Th September 2020
Dec 2020
30 Dec · Board meeting
Meeting on 4 Jan 2021
Nov 2020
28 Nov · Intimation On The Outcome For The Board Meeting Held On 28Th November 2020 And Disclosure Under SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015
23 Nov · Board meeting
Meeting on 28 Nov 20209 Nov · Board meeting
Meeting on 13 Nov 2020: quarterly results1 Nov · Intimation Of Incorporation Of Wholly Owned Subsidiary Company Ref: Intimation Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Oct 2020
29 Oct · Compliance Certificate Under Regulation 40 (9) And 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
19 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....13 Oct · Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended September 30, 2020.
12 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 07 Oct · Board meeting
Meeting on 12 Oct 2020
Sep 2020
21 Sep · Board meeting
Meeting on 25 Sep 202011 Sep · Board meeting
Meeting on 16 Sep 2020: increase in authorised capital
Aug 2020
31 Aug · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....21 Aug · Board meeting
Meeting on 29 Aug 2020: increase in authorised capital and quarterly results6 Aug · Board meeting
Meeting on 8 Aug 2020: amalgamation
Jul 2020
30 Jul · Board meeting
Meeting on 1 Aug 2020: annual general meeting20 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....16 Jul · Results
10 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
18 Jun · Results
16 Jun · Board meeting
Meeting on 18 Jun 2020: audited results6 Jun · Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), Read With SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 Dated May 20, 2020 By Indrayani Biotech Limited (The 'Company')